Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

McNeil Consumer Healthcare initiates voluntary recall

In consultation with the U.S. Food and Drug Administration, McNeil Consumer Healthcare, Division of McNEIL-PPC, Inc. is voluntarily recalling, at the wholesale level, certain lots of TYLENOL® 8 Hour, TYLENOL® Arthritis Pain, and TYLENOL® upper respiratory products, and certain lots of BENADRYL®, SUDAFED PE®, and SINUTAB® products distributed in the United States, the Caribbean, and Brazil.

18 Jan 2011

Oxford Instruments supplying plasma systems for nanotech discovery at Notre Dame

The Midwest Institute for Nanoelectronics Discovery (MIND) has purchased two plasma etch and deposition systems from Oxford Instruments Plasma Technology to further expand and facilitate its research capabilities. The FlexAL Atomic Layer Deposition (ALD) system and the PlasmaPro System100 ICP etch system, will be installed in the Notre Dame Nanofabrication Facility, a 9,000 sq. ft. cleanroom, in the Stinson-Remick Hall of Engineering located on the campus of the University of Notre Dame, Indiana, USA.

17 Jan 2011

Aberdeen reports on QAD Enterprise Applications On Demand SaaS solution

QAD Inc., a leading provider of enterprise software and services for global manufacturing companies, announced today that Aberdeen Group, a leading firm of technology analysts, has published QAD On Demand Gives Manufacturers the Tools They Need to Become Global - its latest Analyst Insight report - in which it cites QAD as a pioneer in delivering a complete Enterprise Resource Planning (ERP) solution in a Software as a Service (SaaS) delivery model.

14 Jan 2011

U.S. Marshals seize Rite-Dent's dental devices

U.S. Marshals, acting under a court order sought by the U.S. Food and Drug Administration, on Jan. 5 and 6, seized all dental devices from Rite-Dent Manufacturing Corporation, located in Hialeah, Fla.

14 Jan 2011

ShangPharma opens new multi-purpose pharma development and cGMP manufacturing facility in Fengxian

ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced commencement of operations on the initial phase of production at the Company's Fengxian facility. This new multi-purpose pharmaceutical development and cGMP manufacturing facility is located in Fengxian in the suburbs of Shanghai, China.

14 Jan 2011

FDA stops operations of N.Y.-based beverage company

At the request of the U.S. Food and Drug Administration, the U.S. Department of Justice today filed a complaint for permanent injunction against a Jamaica, N.Y.-based beverage company to prevent it from processing and distributing juice and other products.

14 Jan 2011

Centice launches integration and solutions platform for Computational Raman Spectroscopy application

Centice Corporation, a pioneer in chemical verification and identification using Raman Spectroscopy and computational sensor technology, announced today the availability of an integration and solutions platform for the application of Computational Raman Spectroscopy to satisfy technology needs in process manufacturing, healthcare, public safety and materials science.

14 Jan 2011

FDA approves Cumberland's Acetadote Injection

Cumberland Pharmaceuticals today announced that it has received approval from the U.S. Food and Drug Administration for a new formulation of Acetadote Injection, the Company's product used to treat acetaminophen poisoning.

13 Jan 2011

PPPI-III conference to focus on fundamental research and industrial application of particulate processing

Over 80% of all pharmaceutical products are in the solid dosage form. Particulate processes therefore abound in the pharmaceutical industry. These include crystallization; drying, granulation, and coating; tablet compaction; fine powder transport, mixing, and blending. These and other particulate processes are used for the large-scale manufacture of tablets and capsules as well as dry powder inhalants for public consumption.

13 Jan 2011

SRI International receives $17.4 million grant to boost treatments for cardiovascular, lung, blood diseases

SRI International, an independent nonprofit research and development organization, announced today that it has been awarded two preclinical services contracts totaling $17.4 million by the National Heart, Lung, and Blood Institute, one of the National Institutes of Health.

13 Jan 2011

Wanxin Optical, Essilor enter joint venture agreement to broaden product range in Chinese market

Essilor International has announced it is taking a 50% stake in Wanxin Optical, one of China's leading manufacturers of ophthalmic lenses, as part of a joint venture agreement.

13 Jan 2011

CE mark approves Vitrolife's SpermFreeze Solution

SpermFreeze Solution, which is used for freeze storage of sperm, has obtained a CE mark and is thereby approved for sales within the European Economic Area.

12 Jan 2011

Intertek announces acquisition of American Analytical Chemistry Laboratories

Intertek, a leading provider of quality and safety solutions serving a wide range of industries around the world, has acquired American Analytical Chemistry Laboratories Corp (AACL), a testing, analytics and research company focusing on food, functional foods, nutritional supplements, cosmeceuticals and pharmaceuticals.

12 Jan 2011

ALLOZYNE completes AZ01 Phase IA clinical trial in relapsing remitting multiple sclerosis

ALLOZYNE, Inc. announced today, the completion of its first Phase IA clinical trial in healthy individuals for AZ01, a PEGylated form of human interferon beta-1b which is being developed for the treatment of relapsing remitting multiple sclerosis. The objectives of the Phase IA trial were to assess safety and tolerability profile in addition to defining its pharmacological properties.

11 Jan 2011

HITRUST designates PwC as a Common Security Framework Assessor

PwC US announced today that the Health Information Trust Alliance (HITRUST) has designated the firm a Common Security Framework (CSF) Assessor, qualified to evaluate and certify security standards of CSF-related services.

11 Jan 2011

Mithridion secures commitments of $1.25 million in new funding

Mithridion, Inc., a privately-owned clinical stage drug development company focusing on serious Central Nervous System disorders, including Alzheimer's disease, announces that it has secured commitments of $1.25 million in new funding.

11 Jan 2011

PakSense launches new class of temperature monitoring device

PakSense, an innovator in sensory solutions for packaging, announced today the launch of the PakSense BIOmed Label product line for use in clinical trials, pharmaceuticals, biologics, vaccines and other healthcare-related material transport.

11 Jan 2011

BiAqua, DSM enter partnership for strain and process development of BiAqua Ferritin

DSM BioSolutions, Royal DSM's microbial fermentation contract manufacturing business, and BiAqua B.V., an innovator in delivering bio-based solutions for serious water contamination issues, today announced that they have entered into an agreement for strain development, process development and production of "BiAqua Ferritin" for BiAqua's core technology to address bio-fouling and arsenic contamination in the water sector.

11 Jan 2011

Discovery Labs provides update on Surfaxin FDA marketing authorization for RDS in premature infants

Discovery Laboratories, Inc., a biotechnology company developing its novel, synthetic, peptide-containing surfactant, is providing an update regarding its efforts to file a Complete Response intended to gain U.S. Food and Drug Administration (FDA) marketing authorization of Surfaxin® for the prevention of respiratory distress syndrome (RDS) in premature infants.

11 Jan 2011

Study: Protein that plays a key role in some antioxidant therapies can promote atherosclerosis

UCLA researchers have found that a protein that plays an important role in some antioxidant therapies may not be as effective due to additional mechanisms that cause it to promote atherosclerosis, or clogging of the arteries.

11 Jan 2011

Manufacturing News and Research

Further Reading

McNeil Consumer Healthcare initiates voluntary recall

Oxford Instruments supplying plasma systems for nanotech discovery at Notre Dame

Aberdeen reports on QAD Enterprise Applications On Demand SaaS solution

U.S. Marshals seize Rite-Dent's dental devices

ShangPharma opens new multi-purpose pharma development and cGMP manufacturing facility in Fengxian

FDA stops operations of N.Y.-based beverage company

Centice launches integration and solutions platform for Computational Raman Spectroscopy application

FDA approves Cumberland's Acetadote Injection

PPPI-III conference to focus on fundamental research and industrial application of particulate processing

SRI International receives $17.4 million grant to boost treatments for cardiovascular, lung, blood diseases

Wanxin Optical, Essilor enter joint venture agreement to broaden product range in Chinese market

CE mark approves Vitrolife's SpermFreeze Solution

Intertek announces acquisition of American Analytical Chemistry Laboratories

ALLOZYNE completes AZ01 Phase IA clinical trial in relapsing remitting multiple sclerosis

HITRUST designates PwC as a Common Security Framework Assessor

Mithridion secures commitments of $1.25 million in new funding

PakSense launches new class of temperature monitoring device

BiAqua, DSM enter partnership for strain and process development of BiAqua Ferritin

Discovery Labs provides update on Surfaxin FDA marketing authorization for RDS in premature infants

Study: Protein that plays a key role in some antioxidant therapies can promote atherosclerosis

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Inside the Alzheimer's Association: Dr. Heather Snyder on Driving Research and Collaboration

Latest Life Science News